Clinical Research

HOME > R&D Achievement > Clinical Research > Article
 
DATE : 16-03-14 14:30
Clinical outcomes of stent thrombosis after drug-eluting coronary stent implantation.
 WRITER : stent
HIT : 1,458  
   C155._Korea_contents_J._2013;13_12_880-892..pdf (707.5K) [0] DATE : 2016-03-14 14:30:12
C155. Kim IS, Jeong MH, Han JB, Jang YI, Jang SJ; Clinical outcomes of stent thrombosis after drug-eluting coronary stent implantation. Korea contents J. 2013;13(12)880-892.

(Abstract)
Stent thrombosis after successful drug-eluting stent(DES) implantation has been reported in around 1% of patients in clinical trials. However, the increased risk of ST associated with DES remains a matter of concern. From 1 June 2003 to 30 June 2013, we investigated clinical characteristics, in-hospital outcomes in 10,273 patients who underwent percutaneous coronary intervention in the Heart Center of CNUH. Overall incidence of ST was 1.30% (134 patients). The incidence of ST according to the stent generations and the timing of ST (n= total, early vs. late vs. very late) were 0.79% (n =81, 26 vs. 12 vs. 43) in first-generation, 0.38% (n=39, 21 vs. 9 vs. 9) in second-generation and 0.14% (n=14, 8 vs 3 vs. 3) in third-generation, (p=0.70). The mortality from ST was significantly higher in early ST group compared to the late and very late ST groups (18.2% vs. 8.3% vs. 3.6%, p=0.042). Overall incidence of ST after DES implantation was 1.30% (134 patients). The in-hospital mortality was significantly higher in early ST group compared to the late and very late ST groups.